Harikrishna Nakshatri

  • 11238 Citations
  • 54 h-Index
1988 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Harikrishna Nakshatri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Genes Medicine & Life Sciences
Transcription Factors Medicine & Life Sciences
Cells Chemical Compounds
Breast Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 2000 2019

Estrogen Receptor alpha
Estrogen Receptors
Estrogens
Breast
Epithelial Cells
Sarcopenia
Neoplasms
Breast Neoplasms
Cachexia
Myocardium
Neoplastic Stem Cells
Breast Neoplasms
Wnt Signaling Pathway
Neoplasms
Drug Therapy
MicroRNAs
Breast Neoplasms
Serum
Neoplasms
RNA

Publications 1988 2019

Cell competition and tumor heterogeneity

Parker, T. M., Henriques, V., Beltran, A., Nakshatri, H. & Gogna, R., Jan 1 2019, (Accepted/In press) In : Seminars in Cancer Biology.

Research output: Contribution to journalReview article

Neoplasms
Cell Communication
Homeostasis
Growth
Therapeutics

Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer

Ni, Y., Schmidt, K. R., Werner, B. A., Koenig, J. K., Guldner, I. H., Schnepp, P. M., Tan, X., Jiang, L., Host, M., Sun, L., Howe, E. N., Wu, J., Littlepage, L. E., Nakshatri, H. & Zhang, S., Dec 1 2019, In : Nature communications. 10, 1, 2860.

Research output: Contribution to journalArticle

Open Access
Death Domain Receptor Signaling Adaptor Proteins
Triple Negative Breast Neoplasms
effectors
vulnerability
death
1 Citation (Scopus)

Dual TGFb/BMP pathway inhibition enables expansion and characterization of multiple epithelial cell types of the normal and cancerous breast

Prasad, M., Kumar, B., Bhat-Nakshatri, P., Anjanappa, M., Sandusky, G., Miller, K., Storniolo, A. M. & Nakshatri, H., Jul 1 2019, In : Molecular Cancer Research. 17, 7, p. 1556-1570 15 p.

Research output: Contribution to journalArticle

Breast
Epithelial Cells
Feeder Cells
Stromal Cells
Heterografts
2 Citations (Scopus)

Genetic ancestry–dependent differences in breast cancer–induced field defects in the tumor-adjacent normal breast

Nakshatri, H., Kumar, B., Burney, H. N., Cox, M. L., Jacobsen, M., Sandusky, G., D'Souza-Schorey, C. & Storniolo, A. M., Jan 1 2019, In : Clinical Cancer Research. 25, 9, p. 2848-2859 12 p.

Research output: Contribution to journalArticle

Tissue Banks
Breast
African Americans
Neoplasms
Estrogen Receptor alpha
17 Citations (Scopus)

An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations

Pulliam, N., Fang, F., Ozes, A. R., Tang, J., Adewuyi, A., Keer, H., Lyons, J., Baylin, S. B., Matei, D., Nakshatri, H., Rassool, F. V., Miller, K. & Nephew, K., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3163-3175 13 p.

Research output: Contribution to journalArticle

Epigenomics
Ovarian Neoplasms
Breast Neoplasms
Mutation
Methyltransferases